NCT03595865 is a NA clinical trial of tafluprostin in Glaucoma; Drugs, sponsored by wangdabo.

Who is sponsoring NCT03595865?

NCT03595865 is sponsored by wangdabo.

What drugs are being tested in NCT03595865?

Interventions in NCT03595865: tafluprostin.

What condition does NCT03595865 study?

NCT03595865 studies Glaucoma; Drugs.

Is NCT03595865 still recruiting?

NCT03595865 is currently status unknown. Last updated 23 July 2018.

Last reviewed 2018-07-23 · How we verify

NCT03595865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy

Status unknown NA Last updated 23 July 2018

What this trial tests

NA trial testing tafluprostin in Glaucoma; Drugs in 60 participants. Status unknown.

Timeline

1 August 2018

Primary endpoint
1 October 2019

1 June 2020

Quick facts

Lead sponsor	wangdabo
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 August 2018
Primary completion	1 October 2019
Estimated completion	1 June 2020

Drugs / interventions tested

tafluprostin — full drug profile →

Conditions studied

Glaucoma; Drugs — all drugs for Glaucoma; Drugs →

Sponsor

wangdabo — full company profile →

Who can join

Adults 18 to 75, any sex, with Glaucoma; Drugs. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A 6-month, parallel-group study of the safety and efficacy of tafluprostin for Chinese patients with posttrabeculectomy residual primary angle-closure glaucoma or posttrabeculectomy residual primary open angle glaucoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03595865 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by wangdabo
Last refreshed: 23 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03595865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing